Hassan Akrami
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hassan Akrami has a total of 103 co-authors. Here are the top co-authors by number of shared publications:
Mohammad Reza Fattahi
Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
7 shared publicationsDiba Borzabadi Farahani
Department of biology, Faculty of science, Razi University, Kermanshah, Iran
6 shared publicationsBehrouz Moradi
Department of biology, Faculty of science, Razi University, Kermanshah, Iran
5 shared publicationsHamid Ahmadieh
5 shared publicationsKiumars Mehdizadeh
Department of biology, Faculty of science, Razi University, Kermanshah, Iran
5 shared publicationsShahram Samiei
5 shared publications
Latest Publications
- Open Access
- 3 August 2026
- Published by Elsevier in Parasite Epidemiology and Control
- Vol. 34, e00530
Molecular evidence of Rdl mutations linked to Fipronil resistance in urban populations of Blattella germanica in Iran
- 3 August 2026
- Published by Elsevier in Parasite Epidemiology and Control
- Vol. 34, e00530
Open AccessMolecular evidence of Rdl mutations linked to Fipronil resistance in urban populations of Blattella germanica in Iran
- Open Access
- 1 November 2025
- Published by Wolters Kluwer Health in Advanced Biomedical Research
- Vol. 14 (1)
Effect of miR-4270 on Tumorigenicity in Gastric Cancer Stem Cells via the Wnt Signaling Pathway
Background: Cancer stem cells and miRNAs are the most important factors in the tumorigenicity of cancers. So, we evaluated the properties of gastric cancer stem-like cells (GCSCs) under treatment using a hsa-miR-4270 inhibitor and a mimic. Materials and Methods: We isolated GCSCs from the MKN-45 cell line using a non-adherence surface method. Then, GCSCs were treated with hsa-miR-4270 inhibitor/mimic with different concentrations, and the cell proliferation was measured with the MTT assay to find the suitable concentration of inhibitor/mimic for following experiments. Apoptosis, angiogenesis, and metastasis were evaluated by DNA laddering, tube formation, zymography and Transwell assay, respectively. Transcription of the genes in Wnt1 signaling was measured by real-time reverse transcriptase-polymerase chain reaction (RT-PCR). Protein levels of Wnt1, CTNNB1P1, and SMARCD1 were evaluated by western blotting, and interactions between genes involved in our study were examined by STRING and Gene mania tools. Results: The results showed that the hsa-miR-4270 inhibitor declined cell proliferation, MMP activity, migration, and angiogenesis, and induced apoptosis. However, the hsa-miR-4270 mimic had opposite effects on those cell functions. The results of the effects of hsa-miR-4270 inhibitor/mimic on the Wnt1 signaling pathway revealed that the arrest of miR-4270 could inhibit the canonical Wnt1 signaling pathway. Conclusions: In summary, hsa-miR-4270 is an oncomir in the tumorigenicity of GC stem cells, which may be considered an appropriate candidate for GC treatment.
- 1 November 2025
- Published by Wolters Kluwer Health in Advanced Biomedical Research
- Vol. 14 (1)
Open AccessEffect of miR-4270 on Tumorigenicity in Gastric Cancer Stem Cells via the Wnt Signaling Pathway
Background: Cancer stem cells and miRNAs are the most important factors in the tumorigenicity of cancers. So, we evaluated the properties of gastric cancer stem-like cells (GCSCs) under treatment using a hsa-miR-4270 inhibitor and a mimic. Materials and Methods: We isolated GCSCs from the MKN-45 cell line using a non-adherence surface method. Then, GCSCs were treated with hsa-miR-4270 inhibitor/mimic with different concentrations, and the cell proliferation was measured with the MTT assay to find the suitable concentration of inhibitor/mimic for following experiments. Apoptosis, angiogenesis, and metastasis were evaluated by DNA laddering, tube formation, zymography and Transwell assay, respectively. Transcription of the genes in Wnt1 signaling was measured by real-time reverse transcriptase-polymerase chain reaction (RT-PCR). Protein levels of Wnt1, CTNNB1P1, and SMARCD1 were evaluated by western blotting, and interactions between genes involved in our study were examined by STRING and Gene mania tools. Results: The results showed that the hsa-miR-4270 inhibitor declined cell proliferation, MMP activity, migration, and angiogenesis, and induced apoptosis. However, the hsa-miR-4270 mimic had opposite effects on those cell functions. The results of the effects of hsa-miR-4270 inhibitor/mimic on the Wnt1 signaling pathway revealed that the arrest of miR-4270 could inhibit the canonical Wnt1 signaling pathway. Conclusions: In summary, hsa-miR-4270 is an oncomir in the tumorigenicity of GC stem cells, which may be considered an appropriate candidate for GC treatment.
- Open Access
- 1 October 2025
- Published by Wolters Kluwer Health in Advanced Biomedical Research
- Vol. 14 (1)
Pantoprazole Inhibited Metastasis and Angiogenesis Through Wnt/β-Catenin Signaling Pathway in Gastric Cancer Stem-Like Cells
Background: The research on different therapy approaches is critical to find an efficient gastric cancer treatment. The processes of new drug production are very expensive and also take about 15 years. Therefore, the use of existing drugs for treating new diseases may be beneficial in pharmaceutical biotechnology. Thus, we investigated the influence of pantoprazole on Wnt signaling pathway, metastasis, stemness markers, and in vitro tube formation in gastric cancer stem-like cells (GCSCs). Materials and Methods: GCSCs were isolated from MKN-45 cells on a nonadhesive surface. Cell viability, angiogenesis, metastasis, and transcription of CTNNB1, WNT1, SMARCD1, CTNNBIP1, KREMEN1, and SUFU genes and protein levels of CTNNBIP1, SMARCD1, and KREMEN1 were measured by trypan blue, tube formation assays, zymography, the real-time RT-PCR, and Western blotting, respectively. Results: Our findings represented that pantoprazole decreased the cell viability, angiogenesis, metastasis, and stemness features of GCSCs. Also, pantoprazole had an inhibitory impact on Wnt signaling pathway by modulating the transcription level of CTNNB1, WNT1, SMARCD1, CTNNBIP1, KREMEN1, and SUFU genes and protein level of CTNNBIP1, SMARCD1, and KREMEN1. Conclusions: We showed that pantoprazole may reduce the tumorigenicity of GCSCs through the Wnt signaling pathway. Therefore, pantoprazole may be an assistance treatment for gastric cancer therapy.
- 1 October 2025
- Published by Wolters Kluwer Health in Advanced Biomedical Research
- Vol. 14 (1)
Open AccessPantoprazole Inhibited Metastasis and Angiogenesis Through Wnt/β-Catenin Signaling Pathway in Gastric Cancer Stem-Like Cells
Background: The research on different therapy approaches is critical to find an efficient gastric cancer treatment. The processes of new drug production are very expensive and also take about 15 years. Therefore, the use of existing drugs for treating new diseases may be beneficial in pharmaceutical biotechnology. Thus, we investigated the influence of pantoprazole on Wnt signaling pathway, metastasis, stemness markers, and in vitro tube formation in gastric cancer stem-like cells (GCSCs). Materials and Methods: GCSCs were isolated from MKN-45 cells on a nonadhesive surface. Cell viability, angiogenesis, metastasis, and transcription of CTNNB1, WNT1, SMARCD1, CTNNBIP1, KREMEN1, and SUFU genes and protein levels of CTNNBIP1, SMARCD1, and KREMEN1 were measured by trypan blue, tube formation assays, zymography, the real-time RT-PCR, and Western blotting, respectively. Results: Our findings represented that pantoprazole decreased the cell viability, angiogenesis, metastasis, and stemness features of GCSCs. Also, pantoprazole had an inhibitory impact on Wnt signaling pathway by modulating the transcription level of CTNNB1, WNT1, SMARCD1, CTNNBIP1, KREMEN1, and SUFU genes and protein level of CTNNBIP1, SMARCD1, and KREMEN1. Conclusions: We showed that pantoprazole may reduce the tumorigenicity of GCSCs through the Wnt signaling pathway. Therefore, pantoprazole may be an assistance treatment for gastric cancer therapy.
- Open Access
- 30 July 2025
- Published by Maad Rayan Publishing Company in Middle East Journal of Digestive Diseases
- Vol. 17 (3) , 209-213
The Correlation Between NTCP rs2296651 Variant and Risk of Hepatitis B, Cirrhosis, and Hepatocellular Carcinoma in Iranian Population
Background: Millions of people are suffering from different types of liver diseases worldwide. Hepatitis B, cirrhosis, and hepatocellular carcinoma (HCC) are the leading causes of death caused by the hepatitis B virus (HBV). HBV needs to interact with the sodium taurocholate co-transporting polypeptide (NTCP) to enter the cytoplasm of the hepatocyte. single nucleotide polymorphism (SNP) with rs2296651 (Ser267Phe, S267F, G>A) variation in the NTCP has been investigated as a reverse association with the function of NTCP and entry of HBV into the cell in the Asian population. We investigated the relationship between the NTCP rs2296651 variant and HBV infection, liver cirrhosis, and HCC in the Iranian population. Methods: Whole blood DNA of 50 healthy individuals as a control group and 90 patients (HBV, cirrhosis, and HCC) were extracted, and the tetra amplification refractory mutation system polymerase chain reaction (tetra-ARMS PCR) was done to identify the genotypes of the samples. Results: Based on our analytical tests using SPSS software, there was a positive and significant association between NTCP rs2296651 in the control group and cirrhosis (P=0.002), as well as between cirrhosis and HBV (P<0.001). However, there was a negative relationship between cirrhosis and HCC (P=0.003). Conclusion: The NTCP rs2296651 variant may confer resistance to HBV infection in the Iranian population.
- 30 July 2025
- Published by Maad Rayan Publishing Company in Middle East Journal of Digestive Diseases
- Vol. 17 (3) , 209-213
Open AccessThe Correlation Between NTCP rs2296651 Variant and Risk of Hepatitis B, Cirrhosis, and Hepatocellular Carcinoma in Iranian Population
Background: Millions of people are suffering from different types of liver diseases worldwide. Hepatitis B, cirrhosis, and hepatocellular carcinoma (HCC) are the leading causes of death caused by the hepatitis B virus (HBV). HBV needs to interact with the sodium taurocholate co-transporting polypeptide (NTCP) to enter the cytoplasm of the hepatocyte. single nucleotide polymorphism (SNP) with rs2296651 (Ser267Phe, S267F, G>A) variation in the NTCP has been investigated as a reverse association with the function of NTCP and entry of HBV into the cell in the Asian population. We investigated the relationship between the NTCP rs2296651 variant and HBV infection, liver cirrhosis, and HCC in the Iranian population. Methods: Whole blood DNA of 50 healthy individuals as a control group and 90 patients (HBV, cirrhosis, and HCC) were extracted, and the tetra amplification refractory mutation system polymerase chain reaction (tetra-ARMS PCR) was done to identify the genotypes of the samples. Results: Based on our analytical tests using SPSS software, there was a positive and significant association between NTCP rs2296651 in the control group and cirrhosis (P=0.002), as well as between cirrhosis and HBV (P<0.001). However, there was a negative relationship between cirrhosis and HCC (P=0.003). Conclusion: The NTCP rs2296651 variant may confer resistance to HBV infection in the Iranian population.
- 23 June 2024
- Published by Wiley in Cell Biology International
- Vol. 48 (9) , 1313-1325
Comprehensive analysis of the prognostic value of glutathione S‐transferases Mu family members in breast cancer
Breast cancer (BC) remains a significant public health concern globally, with a high number of reported cases and a substantial number of deaths every year. Accumulating reactive oxygen species (ROS) and oxidative stress are related to BC and the Glutathione S‐transferases Mu (GSTM) family is one of the most important enzymatic detoxifiers associated with many cancers. In this study, UALCAN, Kaplan‐Meier plotter, bc‐GenExMiner, cBioPortal, STRING, Enrichr, and TIMER databases were employed to carry out a comprehensive bioinformatic analysis and provide new insight into the prognostic value of GSTMs in BC. GSTM2‐5 genes in mRNA and protein levels were found to be expressed at lower levels in breast tumors compared to normal tissues, and reduction in mRNA levels is linked to shorter overall survival (OS) and relapse‐free survival (RFS). The lower mRNA levels of GSTMs were strongly associated with the worse Scarff‐Bloom‐Richardson (SBR) grades (p < 0.0001). The mRNA levels of all five GSTMs were substantially higher in estrogen receptor (ER)‐positive and progesterone receptor (PR)‐positive compared to ER‐negative and PR‐negative BC patients. As well, when nodal status was compared, GSTM1, GSTM3, and GSTM5 were significantly higher in nodal‐positive BC patients (p < .01). Furthermore, GSTM4 had the most gene alteration (4%) among other family members, and GSTM5 showed the strongest correlation with CD4+ T cells (Cor= .234, p = 2.22e‐13). In conclusion, our results suggest that GSTM family members may be helpful as biomarkers for prognosis and as therapeutic targets in BC.
- 23 June 2024
- Published by Wiley in Cell Biology International
- Vol. 48 (9) , 1313-1325
Comprehensive analysis of the prognostic value of glutathione S‐transferases Mu family members in breast cancer
Breast cancer (BC) remains a significant public health concern globally, with a high number of reported cases and a substantial number of deaths every year. Accumulating reactive oxygen species (ROS) and oxidative stress are related to BC and the Glutathione S‐transferases Mu (GSTM) family is one of the most important enzymatic detoxifiers associated with many cancers. In this study, UALCAN, Kaplan‐Meier plotter, bc‐GenExMiner, cBioPortal, STRING, Enrichr, and TIMER databases were employed to carry out a comprehensive bioinformatic analysis and provide new insight into the prognostic value of GSTMs in BC. GSTM2‐5 genes in mRNA and protein levels were found to be expressed at lower levels in breast tumors compared to normal tissues, and reduction in mRNA levels is linked to shorter overall survival (OS) and relapse‐free survival (RFS). The lower mRNA levels of GSTMs were strongly associated with the worse Scarff‐Bloom‐Richardson (SBR) grades (p < 0.0001). The mRNA levels of all five GSTMs were substantially higher in estrogen receptor (ER)‐positive and progesterone receptor (PR)‐positive compared to ER‐negative and PR‐negative BC patients. As well, when nodal status was compared, GSTM1, GSTM3, and GSTM5 were significantly higher in nodal‐positive BC patients (p < .01). Furthermore, GSTM4 had the most gene alteration (4%) among other family members, and GSTM5 showed the strongest correlation with CD4+ T cells (Cor= .234, p = 2.22e‐13). In conclusion, our results suggest that GSTM family members may be helpful as biomarkers for prognosis and as therapeutic targets in BC.
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S13)
Pathogenic α‐synuclein triggers focal tau pathology, developing to various brain areas in Parkinson disease
Background: Parkinson disease (PD) is the second most common neurodegenerative disorder, whose prevalence is 2∼3% in the population over 65. Recent studies have reported enhancing confirmation of tau pathology in PD, however, α‐synuclein accumulation is the significant pathological hallmark of PD. Despite extensive considerations, thus far, the actual spreading mechanism of neurodegeneration has remained elusive in a PD brain. This study aimed to further clarification the development of α‐synuclein and tau pathologies.Method: We employed several PD models, containing cultured neurons treated with either 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) or with recombinant α‐synuclein. Furthermore, we examined dopaminergic neurons of cytokine Interferon‐β knock‐out. Moreover, we tested rats administrated with 6‐hydroxydopamine, Rhesus monkeys injected with MPTP neurotoxin, and then human post‐mortem brains.Result: We observed the α‐synuclein phosphorylation triggers tau pathogenicity. Moreover, we found more widespread phosphorylated tau than α‐synuclein with prion‐like nature in various brain areas. We optionally omitted P‐tau or P‐α‐synuclein from cytokine interferon‐β knock out with respective monoclonal antibodies. We observed that tau immunotherapy prevented neurodegeneration more than α‐synuclein exclusion.Conclusion: Our observations show that the pathogenic tau could be one of the prominent causes of extensive neurodegeneration triggered by PD. Consequently, we could recommend an impressive therapeutic aims to fight the devastating disorder.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S13)
Open AccessPathogenic α‐synuclein triggers focal tau pathology, developing to various brain areas in Parkinson disease
Background: Parkinson disease (PD) is the second most common neurodegenerative disorder, whose prevalence is 2∼3% in the population over 65. Recent studies have reported enhancing confirmation of tau pathology in PD, however, α‐synuclein accumulation is the significant pathological hallmark of PD. Despite extensive considerations, thus far, the actual spreading mechanism of neurodegeneration has remained elusive in a PD brain. This study aimed to further clarification the development of α‐synuclein and tau pathologies.Method: We employed several PD models, containing cultured neurons treated with either 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) or with recombinant α‐synuclein. Furthermore, we examined dopaminergic neurons of cytokine Interferon‐β knock‐out. Moreover, we tested rats administrated with 6‐hydroxydopamine, Rhesus monkeys injected with MPTP neurotoxin, and then human post‐mortem brains.Result: We observed the α‐synuclein phosphorylation triggers tau pathogenicity. Moreover, we found more widespread phosphorylated tau than α‐synuclein with prion‐like nature in various brain areas. We optionally omitted P‐tau or P‐α‐synuclein from cytokine interferon‐β knock out with respective monoclonal antibodies. We observed that tau immunotherapy prevented neurodegeneration more than α‐synuclein exclusion.Conclusion: Our observations show that the pathogenic tau could be one of the prominent causes of extensive neurodegeneration triggered by PD. Consequently, we could recommend an impressive therapeutic aims to fight the devastating disorder.
- Open Access
- 1 March 2023
- Published by Apex Publishing in The Payam-e-Marefat-Kabul Education University
- Vol. 27 (2) , 100-107
Effect of Mir-4270 Inhibitor and Mimic on Viability and Stemness in Gastric Cancer Stem-Like Cells Derived from MKN-45 Cell Line
MicroRNAs (miRNAs) are significant regulatory factors in stem cell proliferation, and change in miRNA expression influences the cancer stem cell viability and gene expression. Herein, we evaluated the effect of the hsa-miR-4270 inhibitor and its mimic on the expression of stem cell markers in gastric cancer (GC) stem-like cells. GC stem-like cells were isolated from the MKN-45 cell line by a non-adherent surface system. The cells were confirmed by differentiation assays using dexamethasone and insulin as adipogenesis-inducing agents and also Staurosporine as a neural-inducing agent. Isolated GC stem-like cells were treated with different concentrations (0, 15, 20, 25, 30, 40, 50, and 60 nM) of hsa-miR-4270 inhibitor and its mimic. The quantity of cell viability was determined by trypan blue method. Transcription of the stem cell marker genes, including CD44, OCT3/4, SOX2, Nanog, and KLF4, was evaluated by real-time RT-PCR. The results showed that GC stem-like cells were differentiated into both adipose cells using dexamethasone and insulin and neural cells by Staurosporine. Treatment of GC stem-like cells with hsa-miR-4270 inhibitor decreased cell viability and downregulated OCT3/4, CD44, and Nanog to 86%, 79%, and 91% respectively. Also, SOX2 and KLF4 were overexpressed to 8.1- and 1.94-folds, respectively. However, hsa-miR-4270 mimic had opposite effects on the cell viability and gene expression of the stem cell markers. The effect of hsa-miR-4270 inhibitor and its mimic on the expression of the stem cell markers in GCSCs indicated that hsa-miR-4270 stimulates the stemness property of GCSCs, likely through stimulating the development of gastric stem cells.
- 1 March 2023
- Published by Apex Publishing in The Payam-e-Marefat-Kabul Education University
- Vol. 27 (2) , 100-107
Open AccessEffect of Mir-4270 Inhibitor and Mimic on Viability and Stemness in Gastric Cancer Stem-Like Cells Derived from MKN-45 Cell Line
MicroRNAs (miRNAs) are significant regulatory factors in stem cell proliferation, and change in miRNA expression influences the cancer stem cell viability and gene expression. Herein, we evaluated the effect of the hsa-miR-4270 inhibitor and its mimic on the expression of stem cell markers in gastric cancer (GC) stem-like cells. GC stem-like cells were isolated from the MKN-45 cell line by a non-adherent surface system. The cells were confirmed by differentiation assays using dexamethasone and insulin as adipogenesis-inducing agents and also Staurosporine as a neural-inducing agent. Isolated GC stem-like cells were treated with different concentrations (0, 15, 20, 25, 30, 40, 50, and 60 nM) of hsa-miR-4270 inhibitor and its mimic. The quantity of cell viability was determined by trypan blue method. Transcription of the stem cell marker genes, including CD44, OCT3/4, SOX2, Nanog, and KLF4, was evaluated by real-time RT-PCR. The results showed that GC stem-like cells were differentiated into both adipose cells using dexamethasone and insulin and neural cells by Staurosporine. Treatment of GC stem-like cells with hsa-miR-4270 inhibitor decreased cell viability and downregulated OCT3/4, CD44, and Nanog to 86%, 79%, and 91% respectively. Also, SOX2 and KLF4 were overexpressed to 8.1- and 1.94-folds, respectively. However, hsa-miR-4270 mimic had opposite effects on the cell viability and gene expression of the stem cell markers. The effect of hsa-miR-4270 inhibitor and its mimic on the expression of the stem cell markers in GCSCs indicated that hsa-miR-4270 stimulates the stemness property of GCSCs, likely through stimulating the development of gastric stem cells.
- 1 February 2023
- Published by Bentham Science Publishers Ltd. in Current Drug Therapy
- Vol. 18 (1) , 68-74
The Effect of Pantoprazole on Tumor Growth and Apoptosis in Gastric Cancer Stem-Like Cells
Background: Gastric cancer is a daunting global problem with unsatisfactory treatment. Due to the key role of Gastric Cancer Stem-like Cells (GCSCs) in all stages of gastric cancer and the failure of contemporary anticancer therapies, many research efforts are focusing on these treatmentresistant cells. Pantoprazole, as recently considered antitumor agent with well-documented effects on tumorigenesis inhibition, has seldom been investigated in GCSCs in previous studies. We aimed to study the influence of pantoprazole on cell proliferation, apoptosis, and the transcription of genes involved in the cell proliferation and apoptosis pathways.Materials and Methods: Herein, we isolated GCSCs from MKN-45 cell line, on a non-adherent surface and then evaluated the effect of pantoprazole on cell growth and apoptosis of GCSCs by means of MTT, DNA laddering and quantitative real-time RT-PCR techniques.Results: Our findings showed that treated cells with pantoprazole decreased cell proliferation and induced apoptosis. PCNA (Proliferating Cell Nuclear Antigen) and antiapoptotic Bcl2 genes were downregulated and Bax and CASP3 proapoptotic genes, as well as tumor suppressor p53 gene, were overexpressed.Conclusion: Our results revealed that pantoprazole induced apoptosis and declined tumor growth and support the idea that pantoprazole played as a promising breakthrough in gastric cancer therapy.
- 1 February 2023
- Published by Bentham Science Publishers Ltd. in Current Drug Therapy
- Vol. 18 (1) , 68-74
The Effect of Pantoprazole on Tumor Growth and Apoptosis in Gastric Cancer Stem-Like Cells
Background: Gastric cancer is a daunting global problem with unsatisfactory treatment. Due to the key role of Gastric Cancer Stem-like Cells (GCSCs) in all stages of gastric cancer and the failure of contemporary anticancer therapies, many research efforts are focusing on these treatmentresistant cells. Pantoprazole, as recently considered antitumor agent with well-documented effects on tumorigenesis inhibition, has seldom been investigated in GCSCs in previous studies. We aimed to study the influence of pantoprazole on cell proliferation, apoptosis, and the transcription of genes involved in the cell proliferation and apoptosis pathways.Materials and Methods: Herein, we isolated GCSCs from MKN-45 cell line, on a non-adherent surface and then evaluated the effect of pantoprazole on cell growth and apoptosis of GCSCs by means of MTT, DNA laddering and quantitative real-time RT-PCR techniques.Results: Our findings showed that treated cells with pantoprazole decreased cell proliferation and induced apoptosis. PCNA (Proliferating Cell Nuclear Antigen) and antiapoptotic Bcl2 genes were downregulated and Bax and CASP3 proapoptotic genes, as well as tumor suppressor p53 gene, were overexpressed.Conclusion: Our results revealed that pantoprazole induced apoptosis and declined tumor growth and support the idea that pantoprazole played as a promising breakthrough in gastric cancer therapy.
- 1 July 2022
- Published by Bentham Science Publishers Ltd. in Current Molecular Medicine
- Vol. 22 (6) , 514-523
The Association Between Hepatitis B Virus Mutations and the Risk of Liver Disease and Hepatocellular Carcinoma
: Hepatitis B virus [HBV], the best-described hepadnavirus, is distributed all around the world and may lead to chronic and acute liver disease, cirrhosis, and hepatocellular carcinoma. Despite the advancement in treatment against HBV, an errorprone reverse transcriptase, which is required for HBV replication as well as host immune pressure, leads to constant evolution and emergence of genotypes, subgenotypes and mutant viruses; so, HBV will remain as a major healthcare problem around the world. This review article mainly focuses on the HBV mutations which correlated to occult HBV infection, immune escape, vaccine failure and eventually liver cirrhosis and HCC. The current study indicated that preS/S region mutations are related to vaccine failure, immune escape, occult HBV infection and the occurrence of HCC. Whereas P region Mutations may lead to drug resistance to NA antivirals. PreC/C region mutations are associated with HBeAg negativity, immune escape, and persistent hepatitis. Moreover, X region Mutations play an important role in HCC development.
- 1 July 2022
- Published by Bentham Science Publishers Ltd. in Current Molecular Medicine
- Vol. 22 (6) , 514-523
The Association Between Hepatitis B Virus Mutations and the Risk of Liver Disease and Hepatocellular Carcinoma
: Hepatitis B virus [HBV], the best-described hepadnavirus, is distributed all around the world and may lead to chronic and acute liver disease, cirrhosis, and hepatocellular carcinoma. Despite the advancement in treatment against HBV, an errorprone reverse transcriptase, which is required for HBV replication as well as host immune pressure, leads to constant evolution and emergence of genotypes, subgenotypes and mutant viruses; so, HBV will remain as a major healthcare problem around the world. This review article mainly focuses on the HBV mutations which correlated to occult HBV infection, immune escape, vaccine failure and eventually liver cirrhosis and HCC. The current study indicated that preS/S region mutations are related to vaccine failure, immune escape, occult HBV infection and the occurrence of HCC. Whereas P region Mutations may lead to drug resistance to NA antivirals. PreC/C region mutations are associated with HBeAg negativity, immune escape, and persistent hepatitis. Moreover, X region Mutations play an important role in HCC development.